Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
(E)-Alkenes as replacements of amide bonds: development of novel and potent acyclic CGRP receptor antagonistsJune J Kim, Michael R Wood, Shawn J Stachel, et al.Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chiralityMichael R Wood, Kathy M Schirripa, June J Kim, et al.Bioorganic & Medicinal Chemistry Letters|March 15, 2006
5-Piperazinyl pyridine carboxamide bradykinin B1 antagonistsScott D Kuduk, Christina Ng Di Marco, Ronald K Chang, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibilityMichael R Wood, Kathy M Schirripa, June J Kim, et al.Journal of Medicinal Chemistry|February 17, 2006
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.Journal of Medicinal Chemistry|January 19, 2007
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonistsScott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.ACS Medicinal Chemistry Letters|January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose ProjectionsH Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.ACS Medicinal Chemistry Letters|February 16, 2023
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's DiseaseAnthony J Roecker, Kathy M Schirripa, H Marie Loughran, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.Pageof 1